Generally treatment with anakinra prevents outbreaks but they resume if treatment is stopped. In around 15-20% of people, a lymphoproliferative disorder as a complication, most commonly Waldenström's macroglobulinemia, develops. AA amyloidosis has also been reported in people with<unk> . The life span in patients with<unk>  has not been shown to differ much from the general population.
Schnitzler syndrome
Bloom syndrome
Plummer–Vinson syndrome
Senter syndrome
Tropical sprue
Hartnup disease
Food protein-induced enterocolitis syndrome
Juvenile polyposis syndrome